GATA3-AS1
Contents
Annotated Information
Approved Symbol
GATA3-AS1:GATA3 antisense RNA 1
Function
LincRNA GATA3-AS1 might serve as a specific indicator of TH2 response and TH2-associated diseases and might be involved in TH2 cell differentiation.[1]
Expression
GATA3-AS1 is a TH2-specific large intergenic noncoding RNA [1].
LincRNA GATA3-AS1, also termed FLJ45983, is specifically expressed in primary TH2 cells. Further analysis of GATA3-AS1 in 27 human tissues and immune cell types shows that GATA3-AS1 is largely undetectable or had very limited expression, supporting its TH2-specific expression pattern.[1]
Sequence
>gi|549433023|ref|NR_104327.1| Homo sapiens GATA3 antisense RNA 1 (GATA3-AS1), transcript variant 1, long non-coding RNA
000001 GCTGCAGCCG CTGGCCCGAA AATGCTGCTC GGGCGAGCAG GGGTCAGGCG GGAAAAGAAG ACTCCAAATC CACTCTCTGC 000080
000081 TCGCCCCCAG GGCAATGCTG CCAGGAGAGG GAGTGGGTTC CCCCGCAGGC TATCCCACCG ATGGGGCTGA GAGCTTAATT 000160
000161 TGGGGTTTTA TTTGAATTGG AGACATTGTT CCCTCTTCGC TCCTCTACCC CATAAAATTC CCTACAAATG CAAAAATTCG 000240
000241 AGATAGAAGA AGCCGTCCCT GAAAGTAAGT TCTGAAGGAT TCCTTTCATG CGGTGAAGGA ACAACAACAA TATTCAACTT 000320
000321 CACCTTGTTG CTGTCTAACA TTCACCGGAA ACCTCTCCAT AAACAAGGAG AAACGAATGC ACACGCATTT TTGCTAAGAA 000400
000401 GCCCGGGATT AAGATTTAAG GATACAAGCT GAAAGAAAAA ATGAAAAATG CTTCTCCGCG CGTCAATCGA GGGGTGGATG 000480
000481 CGCCACGCAG CGTGAGCCCA GCTCACAGCC ACGCGTAAGA CCAAAAGCTG CCATGGGTTC TGCGCGCGGA GACCTCAGAG 000560
000561 CCGAAGAGAG AAGTCCCCGC GTCAGAAACG CTGCGGATGC CAGGTCTTGA AAATGCTGAC TTCTGAGGCT AAGAATTATT 000640
000641 TCAAAGACAA AAAGAAAAGA CTGGTGAGGA GGCCTTCCGG TGCAAGGGCG CCTATCCGCT AATTTTGGAT GGGGAAGTAG 000720
000721 GGATTATTCG TTTAAATTCA ATCGCGAGCA CCAAGTCGGA CTGGCCGGGG ATGGAGAAGG GCAACCCCCA CCTTTAGAAA 000800
000801 AATAAAAGAT CTCGAAGGCC AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA 000880
000881 AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA AAAAA
000081 TCGCCCCCAG GGCAATGCTG CCAGGAGAGG GAGTGGGTTC CCCCGCAGGC TATCCCACCG ATGGGGCTGA GAGCTTAATT 000160
000161 TGGGGTTTTA TTTGAATTGG AGACATTGTT CCCTCTTCGC TCCTCTACCC CATAAAATTC CCTACAAATG CAAAAATTCG 000240
000241 AGATAGAAGA AGCCGTCCCT GAAAGTAAGT TCTGAAGGAT TCCTTTCATG CGGTGAAGGA ACAACAACAA TATTCAACTT 000320
000321 CACCTTGTTG CTGTCTAACA TTCACCGGAA ACCTCTCCAT AAACAAGGAG AAACGAATGC ACACGCATTT TTGCTAAGAA 000400
000401 GCCCGGGATT AAGATTTAAG GATACAAGCT GAAAGAAAAA ATGAAAAATG CTTCTCCGCG CGTCAATCGA GGGGTGGATG 000480
000481 CGCCACGCAG CGTGAGCCCA GCTCACAGCC ACGCGTAAGA CCAAAAGCTG CCATGGGTTC TGCGCGCGGA GACCTCAGAG 000560
000561 CCGAAGAGAG AAGTCCCCGC GTCAGAAACG CTGCGGATGC CAGGTCTTGA AAATGCTGAC TTCTGAGGCT AAGAATTATT 000640
000641 TCAAAGACAA AAAGAAAAGA CTGGTGAGGA GGCCTTCCGG TGCAAGGGCG CCTATCCGCT AATTTTGGAT GGGGAAGTAG 000720
000721 GGATTATTCG TTTAAATTCA ATCGCGAGCA CCAAGTCGGA CTGGCCGGGG ATGGAGAAGG GCAACCCCCA CCTTTAGAAA 000800
000801 AATAAAAGAT CTCGAAGGCC AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA 000880
000881 AAAAAAAAAA AAAAAAAAAA AAAAAAAAAA AAAAA
Labs working on this lncRNA
- Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linkoping University, Linkoping, Sweden; CIMed, Centre for Individualised Medicine, Faculty of Health Sciences, Linkoping University, Linkoping, Sweden.
